Fennec Pharmaceuticals (FENC) Retained Earnings (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Retained Earnings of -$229.4 million for Q4 2025, down 18557.12% on a QoQ basis from $1.2 million in Q3 2025, and down 4.43% year-over-year from -$240.1 million in Q4 2024.
Fennec Pharmaceuticals (FENC) Retained Earnings (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Retained Earnings history runs 16 years deep, the most recent figure standing at -$229.4 million for Q4 2025.
- Quarterly Retained Earnings fell 4.43% year-over-year to -$229.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$229.4 million (down 4.43% YoY) and the FY2025 annual result came in at -$229.4 million, down 4.43% from the prior year.
- Retained Earnings was -$229.4 million for Q4 2025 at Fennec Pharmaceuticals, down from $1.2 million in the prior quarter.
- Across five years, Retained Earnings topped out at $215.6 million in Q3 2023 and bottomed at -$229.4 million in Q4 2025.
- A 5-year average of -$65.7 million and a median of $1.2 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings surged 209.81% — and 2024, when it slumped 17773.45%.
- Fennec Pharmaceuticals' Retained Earnings stood at -$179.5 million in 2021, then surged by 100.69% to $1.2 million in 2022, then changed by 0.0% to $1.2 million in 2023, then slumped by 17773.45% to -$219.7 million in 2024, then dropped by 4.43% to -$229.4 million in 2025.
- Business Quant data shows FENC's Retained Earnings at -$229.4 million in Q4 2025, $1.2 million in Q3 2025, and $1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | -229.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -229.42 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | -219.68 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | -206.41 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 215.61 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | 1.24 Mn |
| Sep 30, 2022 | -196.34 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 1.24 Mn |
| Dec 31, 2021 | -179.49 Mn |
| Sep 30, 2021 | -175.06 Mn |
| Jun 30, 2021 | -170.90 Mn |
| Mar 31, 2021 | -166.87 Mn |